Literature DB >> 25798243

Pediatric severe pseudomembranous enteritis treated with fecal microbiota transplantation in a 13-month-old infant.

Jiayi Wang1, Yongmei Xiao2, Kai Lin2, Feifei Song2, Ting Ge2, Ting Zhang2.   

Abstract

Fecal microbiota transplantation (FMT) is a procedure used to restore the intestinal microbiota of a diseased individual using indigenous intestinal microorganisms from a healthy donor. The current case report presents the first case of a 13-month-old male with severe pseudomembranous enteritis (PME) treated with FMT. The infant was admitted to Shanghai Children's Hospital with a 2-month history of diarrhea, and a 1.5-month history of retractable edema, hypoalbuminemia, electrolyte disturbance and malnutrition. Besides necessary nutritional support, the patient was treated twice with oral metronidazole combined with or without vancomycin. Diarrhea was partially remitted. However, the infant had bloody or dark-green feces, and a distended abdomen. On day 96 from the initiation of the disease, a single FMT via a nasal jejuna feeding tube was performed. From day 2 until 4 months post-FMT, the patient presented with no diarrhea, normal feces and a satisfactory weight. To the best of our knowledge, this is the first pediatric PME treated with FMT. The current data show that FMT is an efficient choice for recurrent clostridium difficile infection and PME in adults and a few pediatric cases. Due to a lack of safety and effectiveness data, treatment should be cautiously applied in the pediatric population.

Entities:  

Keywords:  children; clostridium difficile infection; fecal microbiota transplantation; pseudomembranous enteritis

Year:  2014        PMID: 25798243      PMCID: PMC4360647          DOI: 10.3892/br.2014.403

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  7 in total

Review 1.  Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

Authors:  Christina M Surawicz; Lawrence J Brandt; David G Binion; Ashwin N Ananthakrishnan; Scott R Curry; Peter H Gilligan; Lynne V McFarland; Mark Mellow; Brian S Zuckerbraun
Journal:  Am J Gastroenterol       Date:  2013-02-26       Impact factor: 10.864

2.  Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol.

Authors:  George Russell; Jess Kaplan; Maryjane Ferraro; Ian C Michelow
Journal:  Pediatrics       Date:  2010-06-14       Impact factor: 7.124

3.  Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.

Authors:  Lawrence J Brandt; Olga C Aroniadis; Mark Mellow; Amy Kanatzar; Colleen Kelly; Tina Park; Neil Stollman; Faith Rohlke; Christina Surawicz
Journal:  Am J Gastroenterol       Date:  2012-03-27       Impact factor: 10.864

4.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

5.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

Review 6.  Bacteriotherapy using fecal flora: toying with human motions.

Authors:  Thomas J Borody; Eloise F Warren; Sharyn M Leis; Rosa Surace; Ori Ashman; Steven Siarakas
Journal:  J Clin Gastroenterol       Date:  2004-07       Impact factor: 3.062

Review 7.  Clostridium difficile Infection in children.

Authors:  Julia Shaklee Sammons; Philip Toltzis; Theoklis E Zaoutis
Journal:  JAMA Pediatr       Date:  2013-06       Impact factor: 16.193

  7 in total
  7 in total

Review 1.  Fecal microbiota transplantation in children: a brief review.

Authors:  Suchitra K Hourigan; Maria Oliva-Hemker
Journal:  Pediatr Res       Date:  2016-03-16       Impact factor: 3.756

Review 2.  Fecal microbiota transplantation for severe clostridium difficile infection after left ventricular assist device implantation: a case control study and concise review on the local and regional therapies.

Authors:  Zeina Z Berro; Righab H Hamdan; Israa H Dandache; Mohamad N Saab; Hussein H Karnib; Mahmoud H Younes
Journal:  BMC Infect Dis       Date:  2016-05-27       Impact factor: 3.090

Review 3.  Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease.

Authors:  Alice Yuxin Wang; Jelena Popov; Nikhil Pai
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

Review 4.  Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation.

Authors:  Yvette H van Beurden; Max Nieuwdorp; Pablo J E J van de Berg; Chris J J Mulder; Abraham Goorhuis
Journal:  Therap Adv Gastroenterol       Date:  2017-02-08       Impact factor: 4.409

Review 5.  Current and future applications of fecal microbiota transplantation for children.

Authors:  Chien-Chang Chen; Cheng-Hsun Chiu
Journal:  Biomed J       Date:  2021-11-12       Impact factor: 7.892

6.  Atypical Presentation of C. Difficile Infection: Report of a Case with Literature Review.

Authors:  Salman A Khan; Arooge Towheed; Sibghat Tul Llah; Aref Bin Abdulhak; Nancy R Tilson-Mallett; Alan Salkind
Journal:  Cureus       Date:  2016-04-08

7.  Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children.

Authors:  Shaaz Fareed; Neha Sarode; Frank J Stewart; Aneeq Malik; Elham Laghaie; Saadia Khizer; Fengxia Yan; Zoe Pratte; Jeffery Lewis; Lilly Cheng Immergluck
Journal:  PeerJ       Date:  2018-05-30       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.